Name | Number of supported studies | Average coverage | |
---|---|---|---|
enteroendocrine cell | 4 studies | 43% ± 22% |
Insufficient scRNA-seq data for expression of RFX6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 181.33 | 328 / 328 | 51% | 5.14 | 90 / 178 |
adrenal gland | 66% | 120.95 | 170 / 258 | 41% | 6.40 | 94 / 230 |
prostate | 73% | 21.30 | 179 / 245 | 30% | 1.55 | 152 / 502 |
stomach | 79% | 206.62 | 283 / 359 | 11% | 0.67 | 31 / 286 |
intestine | 51% | 32.70 | 494 / 966 | 11% | 0.91 | 59 / 527 |
breast | 41% | 21.97 | 189 / 459 | 7% | 0.53 | 82 / 1118 |
bladder | 38% | 12.81 | 8 / 21 | 3% | 0.13 | 16 / 504 |
lung | 33% | 5.61 | 189 / 578 | 6% | 0.43 | 70 / 1155 |
brain | 21% | 3.80 | 549 / 2642 | 0% | 0.00 | 1 / 705 |
esophagus | 4% | 0.82 | 63 / 1445 | 11% | 1.12 | 20 / 183 |
uterus | 13% | 1.57 | 22 / 170 | 1% | 0.05 | 6 / 459 |
ovary | 11% | 1.13 | 20 / 180 | 0% | 0.01 | 2 / 430 |
adipose | 10% | 1.13 | 123 / 1204 | 0% | 0 | 0 / 0 |
skin | 5% | 0.60 | 83 / 1809 | 2% | 0.04 | 8 / 472 |
liver | 1% | 0.09 | 2 / 226 | 4% | 0.17 | 18 / 406 |
muscle | 5% | 0.61 | 39 / 803 | 0% | 0 | 0 / 0 |
thymus | 4% | 0.42 | 27 / 653 | 0% | 0.00 | 1 / 605 |
kidney | 3% | 0.36 | 3 / 89 | 0% | 0.01 | 1 / 901 |
spleen | 2% | 0.24 | 4 / 241 | 0% | 0 | 0 / 0 |
heart | 1% | 0.13 | 11 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.04 | 6 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003309 | Biological process | type B pancreatic cell differentiation |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0003311 | Biological process | pancreatic D cell differentiation |
GO_0003310 | Biological process | pancreatic A cell differentiation |
GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0090104 | Biological process | pancreatic epsilon cell differentiation |
GO_0031018 | Biological process | endocrine pancreas development |
GO_0042593 | Biological process | glucose homeostasis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RFX6 |
Protein name | DNA-binding protein RFX6 (Regulatory factor X 6) (Regulatory factor X domain-containing protein 1) |
Synonyms | RFXDC1 |
Description | FUNCTION: Transcription factor required to direct islet cell differentiation during endocrine pancreas development. Specifically required for the differentiation of 4 of the 5 islet cell types and for the production of insulin . Not required for pancreatic PP (polypeptide-producing) cells differentiation. Acts downstream of NEUROG3 and regulates the transcription factors involved in beta-cell maturation and function, thereby restricting the expression of the beta-cell differentiation and specification genes, and thus the beta-cell fate choice. Activates transcription by forming a heterodimer with RFX3 and binding to the X-box in the promoter of target genes . Involved in glucose-stimulated insulin secretion by promoting insulin and L-type calcium channel gene transcription . . |
Accessions | ENST00000332958.3 Q8HWS3 |